Q1 FY27 results, director changes, Bilcare INC winding up approved

Going ConcernRevenue Growth 20pctPat Growth 25pctExceptional ItemRelated Party TransactionsContingent Liabilities IncreasedResults View source PDF Explain this filing

BI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+20.0%Reaction day

₹64.00

prior close

₹69.94

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+19.9% vs market

Healthcare Research Analytics & Technology peers, median of 5sector+0.0%+20.0% vs sector

On the reaction day the stock moved 19.9 pts more than Nifty Microcap 250 and 20.0 pts more than its Healthcare Research Analytics & Technology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+9.8

10m

+9.8

15m

+9.8

30m

+9.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+20.0+0.1+19.9+0.0+20.0

Next day

+44.0+0.2+43.8-1.3+45.3

+58.4+0.6+57.8-0.2+58.6

+42.6-0.0+42.6-0.9+43.5

+50.4+0.5+49.9+0.1+50.3

+48.6+0.8+47.8-0.1+48.8

+45.6+0.6+45.0-1.0+46.6

15d

+49.8+1.3+48.5+0.6+49.2

+52.4-1.4+53.8-3.0+55.4

+43.9-0.6+44.5-10.8+54.7

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Research Analytics & Technology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Bilcare reported Q1 FY27 consolidated revenue of Rs. 225.86 cr (up 21% YoY) and PAT of Rs. 14.97 cr vs Rs. 7.85 cr. Standalone PAT swung to Rs. 0.91 cr from a loss of Rs. 6.99 cr. Board appointed Mohan Bhandari as Executive Director, reappointed Kavita Bhansali, and approved voluntary winding up of US subsidiary Bilcare INC (nil turnover). Auditor flagged going concern uncertainty due to past operating losses.

Likely market impact

Mixed signals: strong revenue and PAT growth offset by auditor going concern flag and ongoing SFIO investigation. Promoter family leadership reshuffle.